Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly: NIA SCORE
Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly: NIA SCORE
批准号:
10634259
负责人:
David M. Hasan
金额:
$114.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-15 至 2025-03-31
关键词:
AdultAffectAgeAlzheimer&aposs DiseaseAmygdaloid structureAnatomyAngiographyAngioplastyAreaArteriesAtherosclerosisBiological MarkersBlood VesselsBlood flowBypassCaliberCarotid ArteriesCarotid EndarterectomyCerebrovascular CirculationCerebrumCervicalClassificationClinicalClinical TrialsCognitiveCreatineDataDementiaDevelopmentEnrollmentFailureHippocampus (Brain)HybridsImpaired cognitionIncidenceInternal carotid artery structureInterventionIpsilateralIschemic StrokeLesionLimbic SystemMagnetic Resonance ImagingMeasuresMedicalMeta-AnalysisMethodsMinorN-acetylaspartateNatural HistoryNeurocognitive DeficitNeuropsychologyOutcomeOutcome MeasureOxygenPatientsPerfusionPhasePilot ProjectsRandomizedRecording of previous eventsRecurrenceResolutionRiskRuptureSpectrum AnalysisStentsStrokeTechniquesTestingTimeTransient Ischemic AttackVascular Dementiaarmartery occlusionbasecerebral blood volumecognitive functioncognitive testingcohortexecutive functionhuman dataimprovedmaleopen labelprospectiveradiological imagingsafety and feasibilityspecific biomarkerssuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary:
Complete occlusion of the internal carotid artery (COICA) by atherosclerotic disease causes
approximately 15%–25% of ischemic strokes in the carotid artery distribution. Additionally, 40% of subjects
with COICA who present with transient ischemic attacks and 70% of COICA who present with stroke have
cognitive decline with significantly increased risk of vascular dementia and Alzheimer's' disease with time.
Our group and others have used an alternative approach to revascularize subjects with COICAs. These
studies showed the feasibility and safety of using endovascular angioplasty and stenting (EAS) and/or hybrid of
both carotid enterectomy (CEA) and EAS to restore cerebral flow to the ipsilateral hemisphere of the COICA.
Furthermore, our group devised a new angiographic and anatomic classification to upfront predict the success
of revascularization using these techniques. This classification was tested in 2 pilot studies and the results
showed robust plausibility to predict upfront the percentage of success anticipated in revascularizing these
lesions using these techniques. In addition, 3 groups including ours showed that revascularization using these
techniques restored cerebral blood flow to the ipsilateral hemisphere of the COICA evident of normalization of
mean transient time (MTT) on CT perfusion (CTP) and significant improvement in the cognitive function.
EAS and hybrid technique restore the caliber of the cervical ICA and therefore, the blood flow to all
involved vessels with clear evidence of complete resolution of penumbra and normalization of MTT on CTP.
This could provide an explanation for the marked improvement of cognitive function.
Best medical management for this cohort maybe sufficient to reduce the risk of recurrent strokes and/or
TIAs but not enough to improve executive and cognitive function and minimize the accelerated risk of vascular
dementia and AD with time. This creates a clinical gap and a must need of an alternative approach to help this
cohort. Therefore, we leverage our data and others to test the primary hypothesis below:
Primary Hypothesis: Revascularizing symptomatic COICA using endovascular techniques (or Hybrid
of carotid endarterectomy and endovascular techniques) will significantly improve cognitive outcome.
To test this hypothesis we will examine these objectives:
Primary Objective: To test the hypothesis that endovascular revascularization of COICA improves
significantly cognitive function measured by Montreal Cognitive Assessment (MoCA) test.
Secondary Objectives: To test the hypothesis that subjects with symptomatic COICAs and mild/moderate
cognitive dysfunction have the following biomarkers: A) Large penumbra (≥50 ml) measured by mismatch
volume of cerebral blood flow (CBF) & MTT on CTP, B) Presence of lactate and decreased N-acetylaspartate
to creatine (Naa/Cr) in the watershed area (specifically centrum semiovale) on MRI-spectroscopy, and C)
Decreased volumes of the hippocampus and amygdala on MRI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
-
批准号:10677785
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2022
-
负责人:David M. Hasan
-
依托单位:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
-
批准号:10637023
-
项目类别:
-
资助金额:$57.44万
-
财政年份:2022
-
负责人:David M. Hasan
-
依托单位:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
-
批准号:10046985
-
项目类别:
-
资助金额:$72.8万
-
财政年份:2020
-
负责人:David M. Hasan
-
依托单位:
The Use of Deferiprone to Improve Subarachnoid Hemorrhage Cognitive Outcome: U-DISCO
-
批准号:10222566
-
项目类别:
-
资助金额:$72.8万
-
财政年份:2020
-
负责人:David M. Hasan
-
依托单位:
15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
-
批准号:10584534
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2019
-
负责人:David M. Hasan
-
依托单位:
15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
-
批准号:9888455
-
项目类别:
-
资助金额:$33.53万
-
财政年份:2019
-
负责人:David M. Hasan
-
依托单位:
15-PGDH as a better therapeutic target than aspirin in decreasing risk of intracranial aneurysm rupture in men and women equally
-
批准号:10569234
-
项目类别:
-
资助金额:$31.7万
-
财政年份:2019
-
负责人:David M. Hasan
-
依托单位:
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
-
批准号:8915779
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2013
-
负责人:David M. Hasan
-
依托单位:
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
-
批准号:8634915
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2013
-
负责人:David M. Hasan
-
依托单位:
Mechanisms of Effect of Aspirin on Cerebral Aneurysms in Mice
-
批准号:8738727
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2013
-
负责人:David M. Hasan
-
依托单位:
Aneurysm Sac Growth as the Etiology of Recurrence in Coiled Cerebral Aneurysms
-
批准号:8420408
-
项目类别:
-
资助金额:$7.29万
-
财政年份:2012
-
负责人:David M. Hasan
-
依托单位:
Aneurysm Sac Growth as the Etiology of Recurrence in Coiled Cerebral Aneurysms
-
批准号:8302899
-
项目类别:
-
资助金额:$7.55万
-
财政年份:2012
-
负责人:David M. Hasan
-
依托单位:
海外基金